|Articles|June 16, 2019
What’s new from Bausch + Lomb for U.S. anterior segment surgeons
Author(s)Julianne Mobilian
Bausch + Lomb provides a company update at the 2019 ASCRS meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Lesion growth rate reduction tops retina specialists' geographic atrophy treatment priorities
3
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
4
ChatGPT-5 overestimates macular hole surgery success, study finds
5






















